Mackenzie Financial Corp Karyopharm Therapeutics Inc. Transaction History

Mackenzie Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.48 - $5.93 $4,987 - $11,925	2,011 Added 14.57%	15,817 $53,000
Q3 2022 Oct 07, 2022	BUY	$4.08 - $5.82 $7,686 - $10,964	1,884 Added 15.8%	13,806 $75,000
Q2 2022 Aug 10, 2022	SELL	$4.15 - $8.37 $102,372 - $206,471	-24,668 Reduced 67.42%	11,922 $54,000
Q1 2020 May 14, 2020	BUY	$14.38 - $27.72 $338,073 - $651,697	23,510 Added 179.74%	36,590 $702,000
Q4 2019 Feb 13, 2020	BUY	$9.23 - $19.67 $120,728 - $257,283	13,080 New	13,080 $251,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $52.7M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.